Invention Grant
US08765692B2 Modified-galactosyl ceramides for staining and stimulating natural killer T cells
失效
用于染色和刺激天然杀伤T细胞的改性半乳糖神经酰胺
- Patent Title: Modified-galactosyl ceramides for staining and stimulating natural killer T cells
- Patent Title (中): 用于染色和刺激天然杀伤T细胞的改性半乳糖神经酰胺
-
Application No.: US13531124Application Date: 2012-06-22
-
Publication No.: US08765692B2Publication Date: 2014-07-01
- Inventor: Paul B. Savage , Luc Teyton , Albert Bendelac
- Applicant: Paul B. Savage , Luc Teyton , Albert Bendelac
- Applicant Address: US CA La Jolla US IL Chicago US UT Provo
- Assignee: The Scripps Research Institute,The University of Chicago,Bringham Young University
- Current Assignee: The Scripps Research Institute,The University of Chicago,Bringham Young University
- Current Assignee Address: US CA La Jolla US IL Chicago US UT Provo
- Agency: Merchant & Gould P.C.
- Main IPC: A61K31/7032
- IPC: A61K31/7032 ; C07H15/06 ; C07H15/10 ; C12N5/0783
Abstract:
Modified glycolipid compounds are provided. Also disclosed are methods for activating an NKT cell, methods of stimulating an immune response in a subject, and methods suitable for labeling NKT cells.
Public/Granted literature
- US20120270815A1 MODIFIED-GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS Public/Granted day:2012-10-25
Information query
IPC分类:
